Kanya Rajangam occupies the position of Chief Medical & Development Officer at Senti Biosciences, Inc.

She is also on the board of Turnstone Biologics, Inc.

In her past career Dr. Rajangam occupied the position of Chief Medical Officer at Cleave Therapeutics, Inc., Chief Medical Officer & Senior Vice President at Atara Biotherapeutics, Inc., Chief Medical Officer of Nkarta, Inc., Associate Medical Director at Exelixis, Inc. and Senior Medical Director at Onyx Pharmaceuticals, Inc.

Kanya Rajangam received a doctorate from Northwestern University and a doctorate from St. John's Medical College.